Safety and efficacy of tamoxifen in boys with Duchenne muscular dystrophy (TAMDMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial Henzi et al.

https://www.thelancet.com/journals/laneur/home?dgcid=hubspot_email_jcr23_laneur&utm_medium=email&_hsmi=272344443&_hsenc=p2ANqtz-9QvDWGlaRcEyTr4RC0QdavddK_O8LMBn0OXmxqDgbePexnMZV630caDKWaJP8Hc80-C5_0n-EnxPJBKmVdCujf-g9GPw&utm_content=272344443&utm_source=hs_automation Oct 2023 Volume 22Number 10p871-970, e11 Sustainable development demands brain health The Lancet Neurology https://www.thelancet.com/journals/laneur/issue/current